These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Upregulation of DNA repair genes in active cirrhosis associated with hepatocellular carcinoma. Zindy P; Andrieux L; Bonnier D; Musso O; Langouët S; Campion JP; Turlin B; Clément B; Théret N FEBS Lett; 2005 Jan; 579(1):95-9. PubMed ID: 15620696 [TBL] [Abstract][Full Text] [Related]
8. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631 [TBL] [Abstract][Full Text] [Related]
9. Hepatic siderosis, fibrosis and cirrhosis: the association with hepatocellular carcinoma in high-risk population. Jaskiewicz K; Banach L; Lancaster E Anticancer Res; 1997; 17(5B):3897-9. PubMed ID: 9427800 [TBL] [Abstract][Full Text] [Related]
10. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Ramm GA; Ruddell RG Semin Liver Dis; 2005 Nov; 25(4):433-49. PubMed ID: 16315137 [TBL] [Abstract][Full Text] [Related]
11. [Premalignant lesions and hepatocellular carcinoma on non cirrhotic liver overloaded with iron]. Attia A; Blanc JF; Saric J; Balabaud C; Bioulac-Sage P Gastroenterol Clin Biol; 2000 Oct; 24(10):955-9. PubMed ID: 11084432 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry. Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713 [TBL] [Abstract][Full Text] [Related]
13. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis. Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144 [TBL] [Abstract][Full Text] [Related]
15. Iron overload in nonalcoholic steatohepatitis. Fujita N; Takei Y Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026 [TBL] [Abstract][Full Text] [Related]
16. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Shimoda R; Nagashima M; Sakamoto M; Yamaguchi N; Hirohashi S; Yokota J; Kasai H Cancer Res; 1994 Jun; 54(12):3171-2. PubMed ID: 8205535 [TBL] [Abstract][Full Text] [Related]
17. Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis. Kabat GC; Rohan TE Cancer Causes Control; 2007 Dec; 18(10):1047-53. PubMed ID: 17823849 [TBL] [Abstract][Full Text] [Related]
18. Role of alcohol in liver carcinogenesis. McKillop IH; Schrum LW Semin Liver Dis; 2009 May; 29(2):222-32. PubMed ID: 19387921 [TBL] [Abstract][Full Text] [Related]
19. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Seitz HK; Stickel F Biol Chem; 2006 Apr; 387(4):349-60. PubMed ID: 16606331 [TBL] [Abstract][Full Text] [Related]
20. Tumour promotion versus tumour suppression in chronic hepatic iron overload. Bloomer SA; Brown KE Cell Biochem Funct; 2015 Jun; 33(4):241-8. PubMed ID: 26059599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]